<DOC>
	<DOC>NCT02834442</DOC>
	<brief_summary>The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-7117 in healthy subjects.</brief_summary>
	<brief_title>A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy and free from clinically significant illness or disease Male or female subjects aged 18 to 55 years or elderly male subjects aged ≥65 A body weight of ≥60 kg for males and ≥50 kg for females, and a body mass index ranging from 18 to 30 kg/m2 Participated in more than three clinical studies involving administration of an IMP in the previous year, or any study within 12 weeks Clinically significant endocrine, thyroid, hepatic, respiratory, gastro intestinal, renal, cardiovascular or skin disease, or history of any significant psychiatric/psychotic illness disorder Clinically relevant abnormal medical history, physical findings or laboratory values</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>